HAG
AMAG

HighPoint Advisor Group’s AMAG Pharmaceuticals AMAG Stock Holding History

HighPoint Advisor Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,333
Closed -$83K – 380
2020
Q1 		$83K Sell
10,333
-1,300
-11% -$11.5K 0.02% 325
2019
Q4 		$133K Sell
11,633
-115
-1% -$1.26K 0.03% 345
2019
Q3 		$110K Sell
11,748
-580
-5% -$6.1K 0.02% 453
2019
Q2 		$108K Buy
+12,328
New +$133K 0.03% 438
2018
Q4 		– Sell
-8,392
Closed -$188K – 364
2018
Q3 		$188K Buy
+8,392
New +$191K 0.05% 312

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighPoint Advisor Group's AMAG Position: Q2 2020 in Review

HighPoint Advisor Group sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 10,333 shares — an estimated $83K sold.

HighPoint Advisor Group first reported a position in AMAG in Q3 2018 and held it in 5 quarters. The position peaked at $188K in Q3 2018. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • HighPoint Advisor Group reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • HighPoint Advisor Group sold 10,333 AMAG Pharmaceuticals shares in Q2 2020, an estimated $83K.
  • HighPoint Advisor Group first reported a position in AMAG Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • HighPoint Advisor Group's AMAG Pharmaceuticals position peaked at $188K in Q3 2018.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on HighPoint Advisor Group's 13F filing for Q2 2020, filed 13 Aug 2020.